Encision Company Top Management
| ECIA Stock | USD 0.17 0.02 10.53% |
Encision employs about 31 people. The company is managed by 7 executives with a total tenure of roughly 122 years, averaging almost 17.0 years of service per executive, having 4.43 employees per reported executive. Analysis of Encision's management performance can provide insight into the company performance.
| Gregory Trudel CEO CEO and President and Director |
| Peter Geary President Vice President - Operations |
Encision |
Encision Management Team Effectiveness
The company has return on total asset (ROA) of (0.0831) % which means that it has lost $0.0831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Encision's management efficiency ratios could be used to measure how well Encision manages its routine affairs as well as how well it operates its assets and liabilities.Encision retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Some institutional investors establish a significant position in pink sheets such as Encision in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Encision, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Encision Workforce Comparison
Encision is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,526. Encision holds roughly 31.0 in number of employees claiming about 2.03% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09. Encision Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Encision Price Series Summation is a cross summation of Encision price series and its benchmark/peer.
Encision Notable Stakeholders
An Encision stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Encision often face trade-offs trying to please all of them. Encision's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Encision's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gregory Trudel | CEO and President and Director | Profile | |
| Peter Geary | Vice President - Operations | Profile | |
| Robert Fries | Independent Director | Profile | |
| David Newton | Co-Founder, VP of Technology and Director | Profile | |
| Vern Kornelsen | Independent Director | Profile | |
| Mala Ray | Controller, Treasurer and Corporate Secretary | Profile | |
| Brian Jackman | VP Marketing | Profile |
About Encision Management Performance
The success or failure of an entity such as Encision often depends on how effective the management is. Encision management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Encision management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Encision management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Encision operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31 people.
Please note, the presentation of Encision's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encision's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Encision's management manipulating its earnings.
Encision Workforce Analysis
Traditionally, organizations such as Encision use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Encision within its industry.Encision Manpower Efficiency
Return on Encision Manpower
| Revenue Per Employee | 243.2K | |
| Revenue Per Executive | 1.1M | |
| Net Income Per Employee | 18.9K | |
| Net Income Per Executive | 83.5K | |
| Working Capital Per Employee | 45.8K | |
| Working Capital Per Executive | 203K |
Complementary Tools for Encision Pink Sheet analysis
When running Encision's price analysis, check to measure Encision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encision is operating at the current time. Most of Encision's value examination focuses on studying past and present price action to predict the probability of Encision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Encision's price. Additionally, you may evaluate how the addition of Encision to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |